The COVID-19 pandemic has greatly accelerated the adoption of wearable technology in healthcare, particularly in the areas of remote monitoring and telemedicine. Devices like smartwatches and medical-grade wearables are now essential tools for managing chronic conditions such as diabetes, offering real-time glucose monitoring capabilities. For instance, Apple Watch users can now directly access glucose data from older DexCom continuous glucose monitoring devices, eliminating the need for reliance on iPhones for data relay and providing immediate access to critical health information.
The wearable technology market is poised for significant growth in the coming years, with innovations in hearables and smartwatches driving the market towards an estimated value of $290.6 billion by 2030, up from $99.5 billion in 2022. Advances in artificial intelligence are also enhancing wearable devices, making them more interactive and intelligent. These technologies are reshaping diabetes management, promoting a more connected and proactive approach to healthcare beyond the pandemic.
As wearable technology continues to evolve, it is important for healthcare providers to stay up-to-date with the latest developments and incorporate them into their patient care plans. By leveraging these technologies, healthcare providers can improve patient outcomes while reducing costs associated with traditional monitoring methods. As a result, it is likely that we will see continued growth in the use of wearable technology within healthcare systems around the world.
To continue reading this article and learn more about how wearable technology is transforming healthcare management beyond chronic conditions such as diabetes, you can subscribe now to gain access to exclusive content and insights on this growing industry.